Showing results (51-60 of 116) with videos related to
Sort By:
Pageof 12
European Journal of Cancer (Oxford, England : 1990)|November 13, 2012
Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysisM Montemurro, H Gelderblom, U Bitz, et al.Journal of the American Society of Nephrology : JASN|December 1, 1996
A novel variant of the beta-subunit of the amiloride-sensitive sodium channel in African AmericansY R Su, M P Rutkowski, C A Klanke, et al.Journal of the American College of Nutrition|March 3, 2016
Strawberries Added to the Usual Diet Suppress Fasting Plasma Paraoxonase Activity and Have a Weak Transient Decreasing Effect on Cholesterol Levels in Healthy Nonobese SubjectsAnna Zasowska-Nowak, Piotr J Nowak, Piotr Bialasiewicz, et al.Molecules (Basel, Switzerland)|March 6, 2021
Influence of Agronomic Practice on Total Phenols, Carotenoids, Chlorophylls Content, and Biological Activities in Dry Herbs Water MaceratesKalina Sikorska-Zimny, Paweł Lisiecki, Weronika Gonciarz, et al.Journal of the American College of Nutrition|June 10, 2014
Addition of strawberries to the usual diet decreases resting chemiluminescence of fasting blood in healthy subjects-possible health-promoting effect of these fruits consumptionPiotr Bialasiewicz, Anna Prymont-Przyminska, Anna Zwolinska, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 21, 2018
Differences in recurrence and survival of extremity liposarcoma subtypesM Vos, H Koseła-Paterczyk, P Rutkowski, et al.Foods (Basel, Switzerland)|May 13, 2026
Preliminary Quality and Safety Evaluation of Lycopene-Based Dietary Supplements: Analysis of Active Compound Content, Microbiological Purity, and Chemical ContaminantsKalina Sikorska-Zimny, Artur Miszczak, Wioletta Popińska, et al.ESMO Open|December 20, 2021
Current landscape of ESMO/ASCO Global Curriculum adoption and medical oncology recognition: a global surveyT Cufer, M Kosty, P Osterlund, et al.European Journal of Cancer (Oxford, England : 1990)|July 10, 2013
An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumoursP Schöffski, D Adkins, J-Y Blay, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2012
Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinibP Reichardt, J-Y Blay, H Gelderblom, et al.Pageof 12